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Abstract 
The article is a review of major historical 
events in the development of the methods 
of endovascular approach of arteriovenous 
malformations (AVM) starting with the first 
cerebral angiography performed on a dog in 
1926, Serbinenko’s embolization 
techniques of cerebral vascular lesions using 
detachable balloons in 1974, ending with 
January 1991 when the first embolization 
with GDC (Guglielmi detachable coils) was 
done on a brain aneurysm. It’s considered 
that there are approximately 1,100 patients 
diagnosed with cerebral arteriovenous 
malformation treated with GDC each 
month. 
Key words: endovascular, emboli-
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Immediately after the discovery of X rays 
in 1895, in Vienna, Hascheck and 
Lindenthal visualized blood vessels by 
injecting an opaque substance into dead 
bodies (1). In 1926, Moniz (2) performed 
the first angiography in dogs by injecting a 
solution of lithium Bromide and Strontium 
obtaining the first image of cerebral 
circulation.  
The first electrothermic thrombosis of a 
cerebral aneurysm was achieved by a 
transorbital insertion of a silver wire 
introduced through a special needle, the 
wire was heated to 80 ° C for 40 seconds. 
In 1960, Mullan and his colleagues (3) 
studied different methods to induce 
aneurism thrombosis. In a preliminary 
study, they achieved a complete thrombosis 
in dogs by inserting small electrodes 
directly into the vessel wall and applying an 
electric current. Subsequently, these 
authors have reported the treatment of 10 
cerebral aneurysms by producing electro 
thrombosis. Under fluoroscopic guidance, 
thrombosis was initiated by passing an 
electric current through a needle electrode 
inserted into the aneurysm. 
Gallagher described his method called 
'pilojection' which consists in introducing 
horse and dog hair in the aneurysmal sac 
(4). 
Luessenhop and Velasques, in the early 
1960s, showed that navigation and 
catheterization through the cerebral vessels 
would be easier and without complications 
if there were used approximately equal 
pressures to the systolic blood pressure (5). 
In 1966, for navigation in cerebral 
arteries Frei (6) used special catheters 
which had micro magnets inserted at their 
tip and which could be guided by an 
external magnetic field. 
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Yasargil, who had experience both in 
cerebral angiography and in stereotactic 
therapy tried to inject iron particles in the 
cerebral vessels and to guide them towards 
by using stereotactic magnets. This attempt 
failed due to technical reasons. A student of 
Yasargil, John Alksne, used both iron 
particles and a combination of acrylic 
mixture and micro particles of iron (7). 
Hilal in 1974 also used the magnetic 
directed catheters (8). 
The first stage of endovascular treatment 
of cerebral AVM was to occlude the feeder 
vessel to the cerebral AVM (Figure 1). This 
treatment was successful in some cases (in 
the occlusion of internal carotid artery-
ICA- with detachable balloons just 
proximal to the AVM or by occlusion of 
both vertebral arteries (VA) in post cranial 
fossa AVMs). These occlusions are 
preceded by vascular occlusion tests. 
Cerebral artery occlusion test with non 
detachable balloons aims to assess the 
tolerance of these vessels to that occlusion. 
The goal is to treat huge AVMs-C that can 
not be selectively obliterated. It also 
evaluates the arterial supplantation provided 
by Willis polygon (ICA test occlusion). An 
intravenous heparin bolus injection of 5000 
IU is administered at the beginning of the 
test. Two arterial ways are used: either the 
femoral way or the carotid way of the 
AVM-C side and a femoral way to study the 
supplantations (Figure 2). 
Hemispheric cerebral blood flow on 
each side is measured by the ICA injection 
of isotope (xenon 133). Middle cerebral 
artery (MCA) blood flow velocity is also 
measured bilaterally with a transcranial 
Doppler. These data once obtained, the 
balloon is inserted in the intracavernous 
segment of ICA. Then the balloon is 
inflated in order to obtain ICA occlusion. 
This procedure should not exceed 30 
minutes. 
 
Figure 1 AVM-C occipital (A, B), partial embolization 
(C) - control after two months (D) (15) 
 
 
Figure 2 The femoral approach 
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During occlusion the following 
parameters should be observed: 
• clinical tolerance (sensory, kinaesthetic 
and superior functions); 
• Doppler examination (Figure 3) is 
performed for three or four times within 30 
minutes (a bigger asymmetry than 25% 
between the two hemispheres in MCA 
blood flow velocity is not allowed); 
• blood flow is measured at 2, 10 and 20 
minutes by xenon 133 injection in 
controlateral ICA occlusion; 
• the study of arterial supplantations 
through angiography. 
If the mentioned criteria are not 
fulfilled, the test is rendered negative. The 
balloon is deflated and a temporo-Sylvian 
anastomosis is performed. The interval 
between test repeating and performing 
temporo-Sylviene anastomosis is between 
15 days and 1 month. 
The test with diamox (acetazolamide) 
can be used in order to study the cerebral 
circulation, and especially the collateral 
circulation. The acetazolamide is a carbonic 
anhydrase inhibitor that inhibits the 
conversion of carbonic acid to CO2 and 
H2O in the brain causing acidosis and 
decreased pH. These transformations lead 
to vasodilatation, but the acetazolamide 
does not cause low general blood pressure. 
 
Figure 3 Carotid Doppler- ECHO 
The test was initially used to assess 
cerebral circulation in patients with carotid 
stenosis for revascularization procedures. 
Tomography with 133 Xe is performed in 
order to obtain the basic cerebral blood 
flow (CBF). Then 1 mg of diamox is 
injected intravenously and tomography is 
repeated after 15-20 minutes. The two CT 
scans are compared. Response to diamox 
varies from one patient to another. Patients 
with normal collateral circulation have a 
normal response to acetazolamide without 
blood redistribution. This test can be used 
to study the brain areas surrounding the 
AVM-C. (15) 
ALLOCK maneuver is also performed. 
It consists of injecting the VA while ICA is 
being occluded in turn; the size of posterior 
communicating artery is observed (if it is > 
1mm in diameter; bilateral VA occlusion is 
possible ). A study by Fox in 1987 (9) 
performed in 68 patients, showed that only 
13.2% had transient ischemic attacks and 
there was only a case of stroke. 
The second stage of development in 
endovascular treatment of cerebral vascular 
lesions is the selective occlusion of cerebral 
AVMs. In 1974, Serbinenko (10) published 
in the Journal of Neurosurgery the 
endovascular treatment method with 
detachable balloons. The idea of using 
balloons in endovascular treatment came 
after observing children who were holding 
helium-filled balloons in the Red Square in 
Moscow during the May 1 demonstration. 
Serbinenko used latex balloons which were 
obtained by melting rubber bands (11). 
During this period, endovascular treatment 
method for cerebral vascular lesions with 
detachable balloons has become the 
standard method. In time, the main 
disadvantages of this method became 
apparent. Thus, hyper selective 
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catheterization of cerebral vessels is difficult 
due to the impossibility of using guide wire. 
The balloon can not take the irregular shape 
of an ordinary aneurysmal sac. By using 
detachable balloons for occlusion of 
cerebral aneurysms there occur very often 
complications consisting of aneurysmal 
rupture and their recanalization (water-
hammer effect). Detachable balloons are 
currently used in the occlusion of vessels 
with giant, fusiform aneurysms. 
Hilal and Solomon (12) introduced 
pushable platinum coils in AVM-C (push-
them-out-the-end). The big disadvantage 
of these coils is that they can not be 
retrieved. 
While introducing electric current 
through an electrode in an experimental 
aneurysm in 1980, Guido Guglielmi 
observed its accidental detachment. 
Together with Ivan Sepetka, engineer for 
Target Therapeutics, they built GDC 
(Guglielmi detachable coils). In March 
1990, at UCLA (University of Columbia 
Los Angeles), after the failure of a 
detachable balloon occlusion of a carotid-
cavernous fistula caused by a ruptured 
cavernous sinus aneurysm, two venous 
GDC were used for the first time, which 
led to permanent occlusion of the fistula. In 
the same place, at UCLA, in January 1991 
(13) the first GDC embolization of cerebral 
aneurysm was performed, and in 1995 
United States Food and Drug 
Administration approved the use of GDC. 
By 2000, over 60,000 worldwide patients 
with cerebral aneurysms and cerebral 
arteriovenous malformations were treated 
with GDC and it is assumed that 
approximately 1,100 patients are treated 
with GDC every month (Figure 4). 
 
 
Future development of endovascular 
treatment of cerebral AVM will probably 
know two ways of evolution. The first way 
would be to develop imaging techniques, 
especially the endoluminal ones 
(endoscopy, angiography) with real-time 
streaming. The second way of development 
would be to find an ideal embolization 
agent (14) with the following qualities: it 
must adjust itself to AVM-C shape, not 
affect the nutritional vessel, absorb the 
energy transmitted to AVM-C walls 
through pulses and prevent the further 
growth of AVM-C (Figure 5). 
Study  
In the period January 1, 2000 - 
December 31, 2009 a total of 426 patients 
with cerebral arteriovenous malformations 
[AVM] were hospitalized in the 
Neurosurgery I Clinic of the "Bagdasar - 
Arseni" Emergency Hospital. All the cases 
were investigated in the clinic with a view 
to setting up a good quality positive 
diagnosis by brain CT scan with contrast 
substance or MRI with brain angio-MRI. 
 
 
Figure 4 embolization with GDC (14) 
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Figure 5 left parietal AVM-C multistage 
cyanoacrylate embolization (16) 
 
In order to evaluate the 
angioarchitecture and the hemodynamics of 
the nidus, and to determine the opportunity 
of the surgical, endovascular treatment 
indication by embolization or Gamma-
Knife radiosurgery of the AVMs, all the 
patients were investigated by carotid 
bilateral and vertebral digital sustraction 
angiography (DSA) (the so-called "four 
vessels angiography"). The patients 
diagnosed with cavernous vascular 
malformation following CT investigation 
and brain MRI, undertook cerebral 
angiography only in the case of suspected 
association of cavernoma with a vascular 
malformation. 
We excluded from the study the cases 
with super-acute evolution (massive 
intraparenchimatous brain hemorrhages, 
intraventricular hemorrhages or massive 
hemorrhages of the brain trunk) in which 
the time elapsed from admission to the 
death only allowed for urgent resuscitation 
and hemodynamic stabilization to be 
applied, and did not allowed one of the 
therapy methods specific for vascular 
malformation to be applied. 
Because one of the declared purposes of 
the study is to establish the therapeutic 
behavior and to determine the efficiency of 
the multimodal treatment of cerebral 
arterio - venous malformation, we only 
kept in the study group the patients in 
whom at least one of the established active 
treatment methods were applied: micro-
surgery treatment, endovascular treatment 
or Gamma-knife or the more reserved 
attitude of observation and surveillance of 
the lesions in asymptomatic or 
oligosymptomatic selected cases. 
Thus, the criteria of inclusion and the 
exclusion in the study were established:  
Inclusion criteria: 
- clinical and paraclinical diagnosis (CT 
and/or brain MRI) of cerebral arteriovenous 
malformation; 
- assessment of angioarchitecture and 
hemodynamics by carotid bilateral and 
vertebral digital sustraction angiography 
(DSA); 
- hospitalization in the period 01.01.2000 
– 31.12.2009. 
Exclusion criteria: 
- the patients in whom, irrespective of 
the reasons (death in short time of 
admission, discharge upon demand or 
refusal of the treatment etc.), none of the 
active treatment methods was applied: 
micro-surgery treatment, endovascular 
treatment or Gamma-knife treatment, or 
passive treatment: observation;  
- the patients in whom the post-
procedural follow-up period was less than 6 
months; 
- the patients who never appeared in the 
post-procedural control. 
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Following the application of the above 
criteria, a group of 375 patients who meet 
all the six inclusion and exclusion criteria 
resulted. 
Out of the 375 patients, in comparison 
to the 246 patients who undertook surgery, 
the remaining 129 patients benefited of 
multimodal treatment or other alternative 
therapy as follows: 
- 46 patients (35.66%) benefited of 
stereotactic radiosurgery; 
- 53 patients (41.08%) benefited of 
embolization; 
- 19 patients (14.73%) were followed up 
clinically and paraclinically;  
- 11 patients (8.53%) benefited of 
multimodal treatment, out of which 
• 4 patients (3.1%) received surgery and 
then radiotherapy by Gamma-Knife for the 
residual nidus; 
• 5 patients (3.8%) were treated by 
embolization in the first phase and then 
they were irradiated by stereotactic method; 
• 2 patients (1.5%) needed a complex, 
sequential treatment: embolization - 
surgery - Gamma-Knife or surgery - 
embolization - Gamma-Knife. (Figure 6) 
We divided the study period in two: the 
patients treated with complementary 
therapies before putting into operation of 
the Centre of Excellence in Neurosurgery 
of "Bagdasar - Arseni" Emergency Hospital 
and the afterward period. Thus, we have 
obtained excellent results for the patients 
treated before and after the opening of the 
Center as follows:  
- out of all the 57 cases treated by 
stereotactic radiosurgery 5 patients 
benefited in the period January 2000 - 
October 2004 (in clinics abroad), and the 
remaining 52 patients were treated in our 
hospital; 
- out of the 60 patients treated by 
embolization, in the Neurosurgery I clinic, 
there were sent to clinics abroad 9 cases, 
and the remaining 51 patients were treated 
by embolization with coils or particles with 
Glubran within the Center of Excellence in 
Neurosurgery within our hospital. 
 
246
46
53
452 19
DISTRIBUŢIA  PACIENŢILOR  ÎN  FUNCŢIE  DE 
METODA  TERAPEUTICĂ
TRATAMENT CHIRURGICAL
TRATAMENT  GAMMA-KNIFE
EMBOLIZARE
CHIRURGIE + RADIOCHIRURGIE
EMBOLIZARE + GAMMA-KNIFE
EMBOLIZARE + CHIRURGIE + GAMMA-
KNIFE
OBSERVATIE CLINICA SI PARACLINICA
 
Figure 6 
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So that we have a rate of 8.77% of 
patients who were treated by stereotactic 
radiosurgery method were sent to for 
treatment to clinics abroad, in the first 
period of 58 months, and 91.23% of the 
patients treated in the Center of 
Neurosurgery within our hospital in 62 
months, in the second period. 
From among the patients treated in the 
Neurosurgery Clinic I of the hospital by 
the method of embolization of the arteries 
that nourish the cerebral arteriovenous 
malformations we notice that about 15% of 
patients were treated abroad, as compared 
with the remaining 85% of the cases treated 
in our hospital, in the same periods of time. 
We have a mortality of 5.84% with a 
morbidity of 41.6% in the first phase of the 
study (January 2000 - October 2004) and in 
the second phase (November 2004 - 
December 2009) we have a mortality 3.9% 
with a mortality of 21.8%. 
Clinical Case 
The patient D.C., aged 21 years, 
appeared in 2003 in our clinic with 
headache and commemorative crises of loss 
of conscience with onset about six months 
ago, for additional specialty investigations. 
Brain CT scan reveals paraventricular 
space replacement process in the left 
occiptal horn that comes to contrast upon 
administration, without other cerebro-
ventricular tomodensitometric changes that 
raises the suspicion of a vascular 
malformation (Figure 7). 
Decision is made to perform a "4 vessels" 
cerebral angiography, which shows a left  
parietal arterio-venous malformation with 
nidus of about 5 cm with multiple artery 
afferences from the left pericallous artery 
(which shows increased caliber due to flow 
rate arteriopathy), left posterior cerebral 
artery (also this with an increased caliber), 
left parietal-occipital artery,  without other 
intranidal changes. The superficial venous 
drainage is made in the parietal portion of 
the SSS by a main pedicle represented by a 
cortical sinuous and tortuous dilated vein 
and by 2-3 secondary pedicles represented 
by 2-3 cortical veins with normal caliber, 
and the deep venous drainage is made in 
the right sinus via Galen’s ampoule through 
a very dilated sinuous and tortuous vein. 
The malformation also injects itself from 
right ICA through a pedicle from the right 
anterior communicating artery and it shows 
a minimum displacement to the right of the 
median axis of the vascular tree (Figure 8). 
 
  
Figure 7 Tomographic aspect of a left parietal-
occipital cerebral arteriovenous malformation 
 
  
  
Figure 8 Angiographic aspect of left parietal-
occipital cerebral AVM 
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The diagnosis of Martin-Spetzler left 
parietal-occipital arterial-venous 
malformation  grade IV is put, due to its 
location in an eloquent area, the size of the 
nidus and due to the superficial and deep 
complex drainage. 
Due to the major risks presented by the 
neurosurgical intervention, the assessment 
of the malformation is decided, with a view 
to embolizing it. 
In February 2004 the first embolization 
is practiced with bioactive coils in a clinic 
abroad (Interballcan Medical Center in 
Salonioc-Greece) (Figure 9). 
In February, May and November 2005 
the multi-stadialization of the embolization 
with Glubran particles is continued in the 
Center of Excellence in Neurosurgery of 
the "Bagdasar - Arseni" Emergency Hospital 
(Figure 10). 
Unfortunately, after all the four 
embolization, a rest of the nidus of the 
arteriovenous malformation of about 1.5 
cm remains, as revealed on brain MRI 
(Figure 11), so it is decided irradiation by 
Gamma-Knife in July 2008. The patient is 
neurologically improved under 
anticonvulsant therapy. 
 
  
A B 
 
C 
Figure 9 A. Preembolization;  B.  Postembolization: 
C. Intraembolization 
 
 
  Figure 10  Succesive images after the three 
embolizations 
 
 
Figure 11 MRI image of the nidal rest of parieto-
occipital brain AVM 
Conclusions 
We notice a marked increase in the 
addressability to modern techniques of 
treatment by embolization and stereotactic 
radiosurgery - Gamma-Knife, after the 
opening of the  Center of Excellence in 
Neurosurgery equipped according to the 
European standards, it being the sole center 
of this kind in this country, with significant 
decrease in the morbidity and mortality. 
The analysis of the presented study, 
related to the cerebral arteriovenous 
malformations, the casuistry of 
Neurosurgery Clinic I, reflects the current 
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situation in the Romanian health system 
and in the Romanian neurosurgery in the 
treatment of cerebral arteriovenous 
malformations, the "Bagdasar-Arseni" 
Emergency Hospital being the only center 
in this country where there are met all the 
conditions for application of the three active 
therapies currently practiced anywhere in 
the world, in MAV-C treatment: 
microsurgical treatment, endovascular 
therapy and the Gamma-Knife stereotactic 
radiosurgery, as monotherapy or as 
multimodal approach. 
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